TrialJournal of child and adolescent psychopharmacology2013

Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.

Robert L Findling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.